Benzinga's Top #PreMarket Gainers

shares rose 42.34 percent to $11.80 in pre-market trading after

agreed to acquire Journal Media for $280 million.

shares climbed 14.51 percent to $44.58 in pre-market trading as the company reported that its Phase III Kinect trial of NBI-98854 has met primary endpoint.

shares rose 13.24 percent to $18.05 in pre-market trading. On Wednesday, NovoCure reported the closing of initial public offering.

gained 4.89 percent to $27.23 in pre-market trading. Privately-held Dell is reportedly in merger talks with EMC, according to Dow Jones.

shares rose 2.56 percent to $8 in pre-market trading after surging 22.45 percent on Wednesday.